Literature DB >> 20564751

Human papillomavirus-active head and neck cancer and ethnic health disparities.

Paul M Weinberger1, Mark A Merkley, Sunny S Khichi, Jeffrey R Lee, Amanda Psyrri, Lana L Jackson, William S Dynan.   

Abstract

OBJECTIVES/HYPOTHESIS: Mortality for black males with head and neck squamous cell carcinoma (HNSCC) is twice that of white males or females. Human papillomavirus (HPV)-active HNSCC, defined by the concurrent presence of high-risk type HPV DNA and host cell p16(INK4a) expression, is associated with decreased mortality. We hypothesized that prevalence of this HPV-active disease class would be lower in black HNSCC patients compared to white patients. STUDY
DESIGN: Multi-institutional retrospective cohort analysis.
METHODS: Real-time polymerase chain reaction was used to evaluate for high-risk HPV DNA presence. Immunohistochemistry for p16(INK4a) protein was used as a surrogate marker for HPV oncoprotein activity. Patients were classified as HPV-negative (HPV DNA-negative, p16(INK4a) low), HPV-inactive (HPV DNA-positive, p16(INK4a) low), and HPV-active (HPV DNA-positive, p16(INK4a) high). Overall survival and recurrence rates were compared by Fisher exact test and Kaplan-Meier analysis.
RESULTS: There were 140 patients with HNSCC who met inclusion criteria. Self-reported ethnicity was white (115), black (25), and other (0). Amplifiable DNA was recovered from 102/140 patients. The presence of HPV DNA and the level of p16(INK4a) expression were determined, and the results were used to classify these patients as HPV-negative (44), HPV-inactive (33), and HPV-active (25). Patients with HPV-active HNSCC had improved overall 5-year survival (59.7%) compared to HPV-negative and HPV-inactive patients (16.9%) (P = .003). Black patients were less likely to have HPV-active disease (0%) compared to white patients (21%) (P = .017).
CONCLUSIONS: The favorable HPV-active disease class is less common in black than in white patients with HNSCC, which appears to partially explain observed ethnic health disparities.

Entities:  

Mesh:

Year:  2010        PMID: 20564751      PMCID: PMC3051373          DOI: 10.1002/lary.20984

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  21 in total

1.  Optimisation of DNA and RNA extraction from archival formalin-fixed tissue.

Authors:  N J Coombs; A C Gough; J N Primrose
Journal:  Nucleic Acids Res       Date:  1999-08-15       Impact factor: 16.971

2.  Heterosexual genital sexual activity among adolescent males: 1988 and 1995.

Authors:  G J Gates; F L Sonenstein
Journal:  Fam Plann Perspect       Date:  2000 Nov-Dec

3.  Head and neck cancer in nonsmokers: a distinct clinical and molecular entity.

Authors:  W M Koch; M Lango; D Sewell; M Zahurak; D Sidransky
Journal:  Laryngoscope       Date:  1999-10       Impact factor: 3.325

4.  Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.

Authors:  Jens P Klussmann; Elif Gültekin; Soenke J Weissenborn; Ulrike Wieland; Volker Dries; Hans P Dienes; Hans E Eckel; Herbert J Pfister; Pawel G Fuchs
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

5.  Safer sex knowledge, behavior, and attitudes of inner-city women.

Authors:  S E Hobfoll; A P Jackson; J Lavin; P J Britton; J B Shepherd
Journal:  Health Psychol       Date:  1993-11       Impact factor: 4.267

6.  Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil.

Authors:  Wei Li; Carol H Thompson; Christopher J O'Brien; Edward B McNeil; Richard A Scolyer; Yvonne E Cossart; Michael J Veness; D Murray Walker; Gary J Morgan; Barbara R Rose
Journal:  Int J Cancer       Date:  2003-09-10       Impact factor: 7.396

7.  Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer.

Authors:  Paul M Weinberger; Z Yu; B G Haffty; D Kowalski; M Harigopal; C Sasaki; D L Rimm; A Psyrri
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

8.  Impact of race on outcome after definitive radiotherapy for squamous cell carcinoma of the head and neck.

Authors:  Majid O F Al-Othman; Christopher G Morris; Henrietta L Logan; Russell W Hinerman; Robert J Amdur; William M Mendenhall
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

9.  Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.

Authors:  Kathleen Settle; Marshall R Posner; Lisa M Schumaker; Ming Tan; Mohan Suntharalingam; Olga Goloubeva; Scott E Strome; Robert I Haddad; Shital S Patel; Earl V Cambell; Nicholas Sarlis; Jochen Lorch; Kevin J Cullen
Journal:  Cancer Prev Res (Phila)       Date:  2009-07-29

Review 10.  Differences in cancer incidence, mortality, and survival between African Americans and whites.

Authors:  B Walker; L W Figgs; S H Zahm
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

View more
  24 in total

1.  Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.

Authors:  Franziska Hauck; Michelle Oliveira-Silva; Johannes H Dreyer; Victor José Ferreira Perrusi; Roberto Alfonso Arcuri; Rocio Hassan; Cibele Rodrigues Bonvicino; Mario Henrique M Barros; Gerald Niedobitek
Journal:  Virchows Arch       Date:  2015-03-28       Impact factor: 4.064

2.  Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients.

Authors:  Swati Tomar; Christian A Graves; Diego Altomare; Sangeeta Kowli; Susannah Kassler; Natalie Sutkowski; M Boyd Gillespie; Kim E Creek; Lucia Pirisi
Journal:  Head Neck       Date:  2015-06-15       Impact factor: 3.147

3.  High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.

Authors:  Jeffrey C Liu; Shobha Parajuli; Elizabeth Blackman; Denise Gibbs; Ashley Ellis; Anna Hull; J Robert Beck; Veda Giri; Patrick Iherjirka; Jasvir S Khurana; Camille R Ragin
Journal:  Head Neck       Date:  2015-07-18       Impact factor: 3.147

4.  Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.

Authors:  Sanjib Chaudhary; Koelina Ganguly; Sakthivel Muniyan; Ramesh Pothuraju; Zafar Sayed; Dwight T Jones; Surinder K Batra; Muzafar A Macha
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

5.  Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.

Authors:  Dan P Zandberg; Sandy Liu; Olga Goloubeva; Robert Ord; Scott E Strome; Mohan Suntharalingam; Rodney Taylor; Robert E Morales; Jeffrey S Wolf; Ann Zimrin; Joshua E Lubek; Lisa M Schumaker; Kevin J Cullen
Journal:  Head Neck       Date:  2015-06-30       Impact factor: 3.147

6.  Improved survival with HPV among African Americans with oropharyngeal cancer.

Authors:  Maria J Worsham; Josena K Stephen; Kang Mei Chen; Meredith Mahan; Vanessa Schweitzer; Shaleta Havard; George Divine
Journal:  Clin Cancer Res       Date:  2013-03-26       Impact factor: 12.531

7.  Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.

Authors:  Annekatrin Coordes; Klaus Lenz; Xu Qian; Minoo Lenarz; Andreas M Kaufmann; Andreas E Albers
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-31       Impact factor: 2.503

8.  Emergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007.

Authors:  Dan P Zandberg; Sandy Liu; Olga G Goloubeva; Lisa M Schumaker; Kevin J Cullen
Journal:  Cancer Prev Res (Phila)       Date:  2014-06-10

9.  Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma.

Authors:  Josena K Stephen; George Divine; Kang Mei Chen; Dhananajay Chitale; Shaleta Havard; Maria J Worsham
Journal:  Cancer Clin Oncol       Date:  2013

10.  Human papillomavirus genotype and oropharynx cancer survival in the United States of America.

Authors:  Marc T Goodman; Mona Saraiya; Trevor D Thompson; Martin Steinau; Brenda Y Hernandez; Charles F Lynch; Christopher W Lyu; Edward J Wilkinson; Thomas Tucker; Glenn Copeland; Edward S Peters; Sean Altekruse; Elizabeth R Unger
Journal:  Eur J Cancer       Date:  2015-11-18       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.